Novo Nordisk Announces Major Insulin Price Cut by Up to 75%, Following in the Footsteps of Eli Lilly
Avian Flu H5N1: Fear Over Potential Spread Among Humans and What We Should Know
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
64th ASH Annual Meeting and Exposition: Standard Treatments Face Challenges
Leveraging Synthetic Biology, Microbiome-based Therapies Open Up Possibilities for Clinical Applications
Will Biden’s Biomanufacturing Initiative Kill Korean Partnership?
Mounting Criticisms of FDA’s Accelerated Approval Pathway Could Prompt Changes to the System
How Governments Around the World Should Respond to the Mounting Costs of Gene and Cell Therapy?
Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends
The FDA Issued its First Formal Warning to Companies Selling Delta-8 THC Products
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence